LIFECARE ASA (LIFE.OL) Stock Fundamental Analysis

OSL:LIFE • NO0013355859

0.452 NOK
-0.02 (-3.21%)
Last: Feb 25, 2026, 07:00 PM
Fundamental Rating

2

Taking everything into account, LIFE scores 2 out of 10 in our fundamental rating. LIFE was compared to 65 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of LIFE have multiple concerns. LIFE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year LIFE has reported negative net income.
  • In the past year LIFE has reported a negative cash flow from operations.
  • LIFE had negative earnings in each of the past 5 years.
  • In the past 5 years LIFE always reported negative operating cash flow.
LIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFLIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of LIFE (-144.73%) is worse than 93.85% of its industry peers.
Industry RankSector Rank
ROA -144.73%
ROE N/A
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
LIFE.OL Yearly ROA, ROE, ROICLIFE.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

  • LIFE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIFE.OL Yearly Profit, Operating, Gross MarginsLIFE.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1

2. Health

2.1 Basic Checks

  • LIFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LIFE has been increased compared to 1 year ago.
  • LIFE has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LIFE has an improved debt to assets ratio.
LIFE.OL Yearly Shares OutstandingLIFE.OL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LIFE.OL Yearly Total Debt VS Total AssetsLIFE.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • LIFE has an Altman-Z score of -7.30. This is a bad value and indicates that LIFE is not financially healthy and even has some risk of bankruptcy.
  • LIFE has a worse Altman-Z score (-7.30) than 87.69% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.3
ROIC/WACCN/A
WACC7.83%
LIFE.OL Yearly LT Debt VS Equity VS FCFLIFE.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • LIFE has a Current Ratio of 0.22. This is a bad value and indicates that LIFE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.22, LIFE is doing worse than 93.85% of the companies in the same industry.
  • A Quick Ratio of 0.22 indicates that LIFE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.22, LIFE is doing worse than 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
LIFE.OL Yearly Current Assets VS Current LiabilitesLIFE.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

  • The earnings per share for LIFE have decreased strongly by -40.54% in the last year.
  • The Revenue for LIFE has decreased by -26.10% in the past year. This is quite bad
  • LIFE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.13% yearly.
EPS 1Y (TTM)-40.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.83%
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-65.22%

3.2 Future

  • Based on estimates for the next years, LIFE will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.88% on average per year.
  • The Revenue is expected to grow by 53.02% on average over the next years. This is a very strong growth
EPS Next Y8.12%
EPS Next 2Y10.07%
EPS Next 3Y8.88%
EPS Next 5YN/A
Revenue Next Year-75%
Revenue Next 2Y15.47%
Revenue Next 3Y53.03%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIFE.OL Yearly Revenue VS EstimatesLIFE.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
LIFE.OL Yearly EPS VS EstimatesLIFE.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LIFE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LIFE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LIFE.OL Price Earnings VS Forward Price EarningsLIFE.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIFE.OL Per share dataLIFE.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.07%
EPS Next 3Y8.88%

0

5. Dividend

5.1 Amount

  • No dividends for LIFE!.
Industry RankSector Rank
Dividend Yield 0%

LIFECARE ASA

OSL:LIFE (2/25/2026, 7:00:00 PM)

0.452

-0.02 (-3.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-27
Earnings (Next)N/A
Inst Owners7.56%
Inst Owner ChangeN/A
Ins Owners7.41%
Ins Owner ChangeN/A
Market Cap86.36M
Revenue(TTM)1.82M
Net Income(TTM)-123.69M
AnalystsN/A
Price Target36.72 (8023.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)66.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-50%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 47.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.52
EYN/A
EPS(NY)-1.31
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS0.01
BVpS-0.03
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -144.73%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.13%
Cap/Sales 326.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -7.3
F-Score1
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)168.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)55.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.83%
EPS Next Y8.12%
EPS Next 2Y10.07%
EPS Next 3Y8.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-65.22%
Revenue Next Year-75%
Revenue Next 2Y15.47%
Revenue Next 3Y53.03%
Revenue Next 5YN/A
EBIT growth 1Y-139.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.41%
EBIT Next 3Y6.74%
EBIT Next 5YN/A
FCF growth 1Y-103.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.56%
OCF growth 3YN/A
OCF growth 5YN/A

LIFECARE ASA / LIFE.OL FAQ

What is the ChartMill fundamental rating of LIFECARE ASA (LIFE.OL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LIFE.OL.


Can you provide the valuation status for LIFECARE ASA?

ChartMill assigns a valuation rating of 0 / 10 to LIFECARE ASA (LIFE.OL). This can be considered as Overvalued.


What is the profitability of LIFE stock?

LIFECARE ASA (LIFE.OL) has a profitability rating of 0 / 10.


What is the earnings growth outlook for LIFECARE ASA?

The Earnings per Share (EPS) of LIFECARE ASA (LIFE.OL) is expected to grow by 8.12% in the next year.


Is the dividend of LIFECARE ASA sustainable?

The dividend rating of LIFECARE ASA (LIFE.OL) is 0 / 10 and the dividend payout ratio is 0%.